# A Study to Learn If the Study Medicine Called PF-08049820 Changes How the Body Processes the Other Study Medicines Called Oral Contraceptives, Midazolam, and Dabigatran in Healthy Adult Female Participants

> **NCT07190430** · PHASE1 · ACTIVE_NOT_RECRUITING · sponsor: **Pfizer** · enrollment: 16 (actual)

## Conditions studied

- Atopic Dermatitis

## Interventions

- **DRUG:** PF-08049820
- **DRUG:** Midazolam
- **DRUG:** Dabigatran Etexilate
- **DRUG:** Portia (EE and LN) or equivalent oral tablet

## Key facts

- **NCT ID:** NCT07190430
- **Lead sponsor:** Pfizer
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2025-10-03
- **Primary completion:** 2025-12-15
- **Final completion:** 2025-12-15
- **Target enrollment:** 16 (ACTUAL)
- **Last updated:** 2025-12-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07190430

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07190430, "A Study to Learn If the Study Medicine Called PF-08049820 Changes How the Body Processes the Other Study Medicines Called Oral Contraceptives, Midazolam, and Dabigatran in Healthy Adult Female Participants". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT07190430. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*